: REGN

Regeneron Pharmaceuticals Inc (NASDAQ: REGN)

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of serious medical conditions. The company’s commercial products include EYLEA injection for the treatment of neovascular age-related macular degeneration; and ARCALYST injection for subcutaneous use for the treatment of cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome in… Continue Reading »